Skip to main content
Clinical Trials/ACTRN12616001218482
ACTRN12616001218482
Terminated
未知

Efficacy of cognitive behavioural therapy to treat sleep disturbance and fatigue following traumatic brain injury: a randomised controlled trial

Professor Jennie Ponsford0 sites126 target enrollmentSeptember 2, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Traumatic Brain Injury
Sponsor
Professor Jennie Ponsford
Enrollment
126
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 2, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor Jennie Ponsford

Eligibility Criteria

Inclusion Criteria

  • Participants with mild to severe TBI and self\-reported sleep disturbance (PSQI greater than 5 and/or fatigue (FSS or BFI equal or greater than 4\), recruited via Epworth Hospital after return to the community. Participants will have a history of blunt head trauma with LOC, initial GCS of 3\-14 and/or a period of PTA. They will be aged 17\-65 years and have adequate English skills, cognitive ability, visual acuity and physical ability to complete the questionnaires and therapy, as assessed by their treating neuropsychologist and live within a one\-hour radius of the hospital.

Exclusion Criteria

  • They will have no history of other neurological disorder, no transmeridian travel across \>1 time zone or nightshift work in the preceding 4 weeks, no current use of psychotropic medication illicit drugs or medication affecting sleep or causing fatigue, such as benzodiazepines or hypnotics and no need for surgery during the study period. They will be excluded if screening shows high risk of Obstructive Sleep Apnoea (OSA) which also causes sleep disturbance, EDS and mood changes. They will be permitted to continue whatever medical, psychological or rehabilitative treatment they are receiving, including pharmacological treatment, other than benzodiazepines or hypnotics, provided that the treatment regimen/dose is stable and does not change throughout the study treatment period.

Outcomes

Primary Outcomes

Not specified

Similar Trials